Surrozen Inc stock is traded at $30.03, with a volume of 33,332. It is up +3.55% in the last 24 hours and up +13.88% over the past month. Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
Previous Close:
$29.00
Open:
$29.02
24h Volume:
33,332
Relative Volume:
0.09
Market Cap:
$352.96M
Revenue:
$7.49M
Net Income/Loss:
-$360.50M
P/E Ratio:
-
EPS:
-$41.32
Net Cash Flow:
-$33.68M
1W Performance:
+3.41%
1M Performance:
+13.88%
6M Performance:
-12.01%
1Y Performance:
+140.24%
1-Day Range:
$29.00$30.17
1-Week Range:
$27.96$32.80
52-Week Range:
$11.39$37.83
Surrozen Inc Stock (SRZN) Company Profile
Name
Surrozen IncSector
HealthcareIndustry
BiotechnologyPhone
650-475-2820Address
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS